Easterly Investment Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Easterly Investment Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.09M	Hold	8,536	–	–	0.08%	116
2025 Q4	$1.04M	Hold	8,536	–	–	0.06%	152
2025 Q3	$855K	Sell	8,536 -5,000	-37%	-$450K	0.06%	158
2025 Q2	$1.12M	Sell	13,536 -9,825	-42%	-$784K	0.08%	141
2025 Q1	$1.89M	Buy	23,361 +5,300	+29%	+$474K	0.16%	113
2024 Q4	$1.63M	Hold	18,061	–	–	0.13%	127
2024 Q3	$1.78M	Hold	18,061	–	–	0.14%	126
2024 Q2	$1.67M	Hold	18,061	–	–	0.15%	120
2024 Q1	$1.71M	Sell	18,061 -5,001	-22%	-$464K	0.13%	133
2023 Q4	$2.06M	Sell	23,062 -5,000	-18%	-$371K	0.22%	99
2023 Q3	$2.05M	Buy	28,062 +5,000	+22%	+$399K	0.23%	97
2023 Q2	$1.92M	Buy	23,062 +1,000	+5%	+$83.6K	0.17%	111
2023 Q1	$1.68M	Buy	22,062 +470	+2%	+$39K	0.15%	116
2022 Q4	$1.79M	Buy	21,592 +3,501	+19%	+$283K	0.15%	116
2022 Q3	$1.44M	Sell	18,091 -10,000	-36%	-$843K	0.14%	120
2022 Q2	$2.09M	Buy	28,091 +10,000	+55%	+$751K	0.19%	103
2022 Q1	$1.63M	Buy	+18,091	New	+$1.67M	0.12%	122

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Easterly Investment Partners's XBI Position: Q1 2026 in Review

Easterly Investment Partners held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 8,536 shares worth $1.09M. The position accounts for 0.08% of the portfolio, ranked #116.

Easterly Investment Partners first reported a position in XBI in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.09M in Q2 2022. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Easterly Investment Partners held 8,536 shares of State Street SPDR S&P Biotech ETF worth $1.09M as of Q1 2026.
Easterly Investment Partners left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.08% of Easterly Investment Partners's portfolio in Q1 2026, its #116 holding.
Easterly Investment Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 17 quarters since.
Easterly Investment Partners's State Street SPDR S&P Biotech ETF position peaked at $2.09M in Q2 2022.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Easterly Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.